Cardiovascular & metabolic devices✔ On-site ready
Mavacamten (Camzyos®)
玛伐凯泰胶囊
Generic mavacamten · targeted myocardial inhibitor
Bristol Myers Squibb·United States
Clinical indication
Symptomatic obstructive hypertrophic cardiomyopathy in adults (NYHA II–III), to improve functional capacity and reduce outflow obstruction.
Pilot Zone docket: HN-PILOT-2023-CD014
Batch verification: LOT# B882-US-EXP2026
Cardiovascular & metabolic devices✔ On-site ready
Micra™ AV2 Leadless Pacemaker
无导线双腔起搏器
Transcatheter pacing system · dual-chamber AV synchrony
Medtronic·United States / Ireland
Clinical indication
AV block requiring dual-chamber pacing without transvenous leads or surgical pockets — lower infection and occlusion risk.
Pilot Zone docket: HN-PILOT-2023-MD089
Cath-lab status: Hybrid interventional suite ready
Targeted oncology & immunotherapy✔ On-site ready
Epcoritamab (Epkinly®)
CD3×CD20 双特异性抗体
CD3×CD20 bispecific human IgG1
AbbVie / Genmab·Switzerland / Denmark
Clinical indication
Relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy.
Pilot Zone docket: HN-PILOT-2024-ON033
Cold-chain tracking: 2–8 °C controlled vault
Cardiovascular & metabolic devices✔ On-site ready
Freesolve™ Magnesium Scaffold
可吸收镁合金冠脉支架
Resorbable magnesium drug-eluting coronary scaffold
Biotronik·Germany
Clinical indication
De novo coronary lesions needing temporary scaffolding with full bioabsorption at twelve months.
Pilot Zone docket: HN-PILOT-2023-MD112
Regulatory track: CE marked · RWD priority
Targeted oncology & immunotherapy◷ By reservation
177Lu-vipivotide tetraxetan (Pluvicto®)
镥-177 PSMA 靶向放射配体
PSMA-directed radioligand therapy · lutetium-177
Novartis·Switzerland
Clinical indication
PSMA-positive metastatic castration-resistant prostate cancer after androgen-receptor pathway inhibition and a taxane.
Pilot Zone docket: HN-PILOT-2024-RL005
Isotope logistics: Direct isotope inflow sync
Regenerative implants & cells✔ On-site ready
Vyznova™ Corneal Endothelial Cells
培养人角膜内皮细胞
Cultured human corneal endothelial cell suspension
ActualEyes Inc.·Japan (PMDA)
Clinical indication
Bullous keratopathy from corneal endothelial decompensation — cell injection instead of full-thickness keratoplasty.
Pilot Zone docket: HN-PILOT-2023-RG021
Delivery protocol: Anterior-chamber micro-injection
The catalog above is a demonstration baseline. Availability follows batch inflow and is confirmed in writing by the medical office after on-site qualification (FR-M5-03); it is not an online shop.